Evidence map›Paper›PMID 39861127›Full record

ReviewPharmaceuticals (Basel, Switzerland)2025

Distribution, Phytochemical Insights, and Cytotoxic Potential of the

Fatma Alzahraa Mokhtar, Mariam Ahmed, Aishah Saeed Al Dhanhani, Serag Eldin I Elbehairi, Mohammad Y Alfaifi, Ali A Shati, Amal M Fakhry

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Panoramic Research onInternational journal of molecular sciences · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fatma Alzahraa MokhtarFujairah Research Centre, Sakamkam Road, Fujairah 00000, United Arab Emirates.ORCID 0000-0002-6909-7440
Mariam AhmedFaculty of Pharmacy and Biotechnology, German University in Cairo, New Cairo 11835, Egypt.
Aishah Saeed Al DhanhaniFujairah Research Centre, Sakamkam Road, Fujairah 00000, United Arab Emirates.
Serag Eldin I ElbehairiBiology Department, Faculty of Science, King Khalid University, Abha 9004, Saudi Arabia.ORCID 0000-0003-4680-3215
Mohammad Y AlfaifiBiology Department, Faculty of Science, King Khalid University, Abha 9004, Saudi Arabia.ORCID 0000-0003-4310-3539
Ali A ShatiBiology Department, Faculty of Science, King Khalid University, Abha 9004, Saudi Arabia.ORCID 0000-0003-1800-7238
Amal M FakhryDepartment of Botany and Microbiology, Faculty of Science, Alexandria University, Alexandria 21511, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review evaluates the cytotoxic potential of the

Indexed as

cancer pathway inhibitioncytotoxicitycytotoxic potentialgalactomannannanoparticlesnatural cancer treatmentssecondary metabolitesSesbania

Identifiers

PMID39861127
PMCPMC11768378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.